Please provide your email address to receive an email when new articles are posted on . Patients with rheumatoid arthritis who achieve only a partial response with adalimumab demonstrate a low risk ...

Patients who require biologic disease-modifying antirheumatic drugs (DMARDs) for severe RA are less likely to achieve sustained DMARD-free remission than those not needing the medication. Patients ...

Rheumatoid Arthritis (RA), a chronic autoimmune disorder, is emerging as a serious health concern in India, affecting nearly ...

psoriasis RA biologic treatment The use of biologic agents in treatment of patients rheumatoid arthritis or psoriasis is associated with a significant risk of heptatis B flares. “The emergence of ...

Worries have persisted that cancer survivors in remission might face increased recurrence risk when treated with biologic drugs for autoimmune disease. This Danish study of rheumatoid arthritis ...

Early escalation to biologic therapies after failure of treat-to-target with methotrexate in patients with rheumatoid arthritis (RA) does not significantly reduce the risk for the development of ...

Scientists at Queen Mary, University of London, have announced a new machine-learning-based method for predicting the biological therapy, or biologic, most likely to successfully relieve symptoms for ...